Literature DB >> 12075992

Human umbilical cord blood cells express neural antigens after transplantation into the developing rat brain.

Tanja Zigova1, Shijie Song, Alison E Willing, Jennifer E Hudson, Mary B Newman, Samuel Saporta, Juan Sanchez-Ramos, Paul R Sanberg.   

Abstract

Recently, our laboratory began to characterize the mononuclear cells from human umbilical cord blood (HUCB) both in vitro and in vivo. These cryopreserved human cells are available in unlimited quantities and it is believed that they may represent a source of cells with possible therapeutic and practical value. Our previous molecular and immunocytochemical studies on cultured HUCB cells revealed their ability to respond to nerve growth factor (NGF) by increased expression of neural markers typical for nervous system-derived stem cells. In addition, the DNA microarray detected downregulation of several genes associated with development of blood cell lines. To further explore the survival and phenotypic properties of HUCB cells we transplanted them into the developing rat brain, which is known to provide a conducive environment for development of neural phenotypes. Prior to transplantation, HUCB cells were either cultured with DMEM and fetal bovine serum or were exposed to retinoic acid (RA) and nerve growth factor (NGF). Neonatal pups (1 day old) received unilateral injection of cell suspension into the anterior part of subventricular zone. One month after transplantation animals were perfused, their brains cryosectioned, and immunocytochemistry was performed for identification of neural phenotypes. Our results clearly demonstrated that approximately 20% of transplanted HUCB survived (without immunosuppression) within the neonatal brain. Additionally, double-labeling with cell-type-specific markers revealed that some HUCB-derived cells (recognized by anti-human nuclei labeling) were immunopositive for glial fibrillary acidic protein (GFAP) and few donor cells expressed the neuronal marker TuJ1 (class III beta-tubulin). These findings suggest that at least some of the transplanted HUCB cells differentiated into cells with distinct glial or neuronal phenotypes after being exposed to instructive signals from the developing brain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12075992

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  26 in total

Review 1.  Transplantation of umbilical cord blood stem cells for treating spinal cord injury.

Authors:  Dong-Hyuk Park; Jeong-Hyun Lee; Cesario V Borlongan; Paul R Sanberg; Yong-Gu Chung; Tai-Hyoung Cho
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

2.  Do hematopoietic cells exposed to a neurogenic environment mimic properties of endogenous neural precursors?

Authors:  P Walczak; N Chen; J E Hudson; A E Willing; S N Garbuzova-Davis; S Song; P R Sanberg; J Sanchez-Ramos; P C Bickford; T Zigova
Journal:  J Neurosci Res       Date:  2004-04-15       Impact factor: 4.164

3.  Characterization of neural stem/progenitor cells expressing VEGF and its receptors in the subventricular zone of newborn piglet brain.

Authors:  Jahan Ara; Saskia Fekete; Anli Zhu; Melissa Frank
Journal:  Neurochem Res       Date:  2010-06-15       Impact factor: 3.996

4.  Trophic factor induction of human umbilical cord blood cells in vitro and in vivo.

Authors:  Ning Chen; Siddharth Kamath; Jennifer Newcomb; Jennifer Hudson; Svitlana Garbuzova-Davis; Paula Bickford; Cyndy Davis-Sanberg; Paul Sanberg; Tanja Zigova; Alison Willing
Journal:  J Neural Eng       Date:  2007-04-04       Impact factor: 5.379

5.  Differentiating neurons derived from human umbilical cord blood stem cells work as a test system for developmental neurotoxicity.

Authors:  Mahendra P Kashyap; Vivek Kumar; Abhishek K Singh; Vinay K Tripathi; Sadaf Jahan; Ankita Pandey; Ritesh K Srivastava; Vinay K Khanna; Aditya B Pant
Journal:  Mol Neurobiol       Date:  2014-05-24       Impact factor: 5.590

6.  Development of a tissue-engineered composite implant for treating traumatic paraplegia in rats.

Authors:  S Rochkind; A Shahar; D Fliss; D El-Ani; L Astachov; T Hayon; M Alon; R Zamostiano; O Ayalon; I E Biton; Y Cohen; R Halperin; D Schneider; A Oron; Z Nevo
Journal:  Eur Spine J       Date:  2005-11-15       Impact factor: 3.134

Review 7.  Repairing neural injuries using human umbilical cord blood.

Authors:  Tao Sun; Quan-Hong Ma
Journal:  Mol Neurobiol       Date:  2012-12-30       Impact factor: 5.590

8.  Human umbilical cord blood progenitors: the potential of these hematopoietic cells to become neural.

Authors:  Ning Chen; Jennifer E Hudson; Piotr Walczak; Iwona Misiuta; Svitlana Garbuzova-Davis; Lixian Jiang; Juan Sanchez-Ramos; Paul R Sanberg; Tanja Zigova; Alison E Willing
Journal:  Stem Cells       Date:  2005-08-04       Impact factor: 6.277

Review 9.  Umbilical cord blood research: current and future perspectives.

Authors:  Jennifer D Newcomb; Paul R Sanberg; Stephen K Klasko; Alison E Willing
Journal:  Cell Transplant       Date:  2007       Impact factor: 4.064

10.  Microporation is a valuable transfection method for efficient gene delivery into human umbilical cord blood-derived mesenchymal stem cells.

Authors:  Jung Yeon Lim; Sun Hwa Park; Chang Hyun Jeong; Ji Hyeon Oh; Seong Muk Kim; Chung Hun Ryu; Soon A Park; Jae Geun Ahn; Wonil Oh; Sin-Soo Jeun; Jong Wook Chang
Journal:  BMC Biotechnol       Date:  2010-05-13       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.